Showing results (31-40 of 185) with videos related to

Sort By:
Pageof 19
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 24, 2017
Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein more reliably distinguishes liver fibrosis stages in non-alcoholic fatty liver disease than serum Mac-2 binding proteinMasanori Atsukawa, Akihito Tsubota, Tomomi Okubo, et al.
International Journal of Cancer|May 31, 2017
Pro-angiogenic TIE-2-expressing monocytes/TEMs as a biomarker of the effect of sorafenib in patients with advanced hepatocellular carcinomaHirotaka Shoji, Sachiyo Yoshio, Yohei Mano, et al.
International Heart Journal|July 19, 2021
Clinical Significance of the Fibrosis-4 Index in Patients with Acute Heart Failure Requiring Intensive CareAkihiro Shirakabe, Hirotake Okazaki, Masato Matsushita, et al.
European Journal of Gastroenterology & Hepatology|October 31, 2014
Relationship between HCV dynamics and sustained virological responses in chronic hepatitis C genotype 1b patients treated with telaprevir-based triple therapyAi Nakagawa, Masanori Atsukawa, Akihito Tsubota, et al.
Cancer Medicine|February 27, 2025
Durvalumab Monotherapy in Complex Advanced Hepatocellular Carcinoma: A Real-World Study of Patients Ineligible for Combination ImmunotherapyChihiro Miwa, Sadahisa Ogasawara, Takuya Yonemoto, et al.
Internal Medicine (Tokyo, Japan)|February 15, 2021
Factors Associated with Hepatitis B Surface Antigen Kinetics and Responses in Pegylated Interferon Alpha-2a Monotherapy for Patients with Chronic Hepatitis BNorio Itokawa, Masanori Atsukawa, Akihito Tsubota, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 27, 2019
Association of vitamin D levels and vitamin D-related gene polymorphisms with liver fibrosis in patients with biopsy-proven nonalcoholic fatty liver diseaseTaeang Arai, Masanori Atsukawa, Akihito Tsubota, et al.
Hepatology International|March 31, 2018
Efficacy and safety of ledipasvir/sofosbuvir for genotype 1b chronic hepatitis C patients with moderate renal impairmentTomomi Okubo, Masanori Atsukawa, Akihito Tsubota, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|April 4, 2024
Impact of pemafibrate in patients with metabolic dysfunction-associated steatotic liver disease complicated by dyslipidemia: A single-arm prospective studyHiroki Ono, Masanori Atsukawa, Akihito Tsubota, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 1, 2017
Efficacy and safety of ombitasvir/paritaprevir/ritonavir in dialysis patients with genotype 1b chronic hepatitis CMasanori Atsukawa, Akihito Tsubota, Yohei Koushima, et al.
Pageof 19